REMIMAZOLAM vs REPOTRECTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REMIMAZOLAM vs REPOTRECTINIB: Safety Overview
| Metric | REMIMAZOLAM | REPOTRECTINIB |
|---|---|---|
| Total FAERS Reports | 137 | 187 |
| Deaths Reported | 3 | 27 |
| Death Rate | 2.2% | 14.4% |
| Hospitalizations | 24 | 48 |
| Average Patient Age | 60.4 yrs | 60.8 yrs |
| % Female Patients | 41.5% | 61.1% |
| FDA Approval Date | Oct 6, 2020 | Jun 11, 2024 |
| Manufacturer | Acacia Pharma, Ltd. | E.R. Squibb & Sons, L.L.C. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |